Ads

You May Also Like

Sanofi: Positive Phase 3 results presented for Dupixent® (dupilumab)

Positive Phase 3 results presented for Dupixent® (dupilumab) show significant improvement on multiple measures ...

Retrophin Reports Third Quarter 2018 Financial Results

Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 ...